These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33585037)

  • 21. Children with HIV: improved mortality and morbidity with combination antiretroviral therapy.
    Foster C; Lyall EG
    Curr Opin Infect Dis; 2005 Jun; 18(3):253-9. PubMed ID: 15864104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ; Nesheim S
    Clin Perinatol; 2010 Dec; 37(4):825-42, x. PubMed ID: 21078453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breastfeeding in HIV-positive women: What can be recommended?
    Slater M; Stringer EM; Stringer JS
    Paediatr Drugs; 2010; 12(1):1-9. PubMed ID: 20034337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.
    Kourtis AP
    Drugs; 2002; 62(15):2213-20. PubMed ID: 12381220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Options for prevention of HIV transmission from mother to child, with a focus on developing countries.
    Kuhn L; Peterson I
    Paediatr Drugs; 2002; 4(3):191-203. PubMed ID: 11909011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy in pregnancy: a focus on safety.
    Taylor GP; Low-Beer N
    Drug Saf; 2001; 24(9):683-702. PubMed ID: 11522121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings.
    Ekouevi DK; Tonwe-Gold B; Dabis F
    AIDS Read; 2005 Sep; 15(9):479-80, 487-93. PubMed ID: 16170877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study.
    Protiere C; Fressard L; Mora M; Meyer L; Préau M; Suzan-Monti M; Lelièvre JD; Lambotte O; Spire B; The Apsec Study Group
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
    Celum CL; Robinson NJ; Cohen MS
    J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model.
    Simon MD; Altice FL; Moll AP; Shange M; Friedland GH
    AIDS Care; 2010 Apr; 22(4):462-74. PubMed ID: 20204909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrupting highly active antiretroviral therapy in patients with HIV.
    Ananworanich J; Hirschel B
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):51-60. PubMed ID: 15757457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.
    LeMessurier J; Traversy G; Varsaneux O; Weekes M; Avey MT; Niragira O; Gervais R; Guyatt G; Rodin R
    CMAJ; 2018 Nov; 190(46):E1350-E1360. PubMed ID: 30455270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CROI 2016: Advances in Antiretroviral Therapy.
    Taylor BS; Olender SA; Tieu HV; Wilkin TJ
    Top Antivir Med; 2016; 24(1):59-81. PubMed ID: 27398863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw LC; Irlam JH; Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Dec; (12):CD004246. PubMed ID: 21154355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.